Prior appendectomy does not protect against subsequent development of malignant or borderline mucinous ovarian neoplasms

Gynecologic Oncology

Volumn 132, Issue 2, 2014, Pages 328-333

  Elias, Kevin M ^a,b,c   Labidi Galy, S Intidhar ^a,b   Vitonis, Allison F ^c   Hornick, Jason L ^b,c   Doyle, Leona A ^b,c   Hirsch, Michelle S ^b,c   Cramer, Daniel W ^c,d   Drapkin, Ronny ^a,b,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Appendectomy; Epidemiology; Mucinous ovarian neoplasms; Risk factors

Indexed keywords

BETA CATENIN; CYTOKERATIN 20; CYTOKERATIN 7; MUCIN 2; ORAL CONTRACEPTIVE AGENT; SMAD4 PROTEIN; TRANSCRIPTION FACTOR CDX2; TRANSCRIPTION FACTOR PAX8;

ADULT; APPENDECTOMY; APPENDIX METASTASIS; APPENDIX TUMOR; ARTICLE; BREAST FEEDING; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RISK; CANCER SURGERY; CARCINOID; CASE CONTROL STUDY; COLLOID CARCINOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; METASTASIS; MIDDLE AGED; MUCINOUS APPENDICEAL ADENOCARCINOMA; MUCINOUS COLORECTAL CARCINOMA; MUCINOUS OVARIAN CARCINOMA; MUCINOUS OVARY TUMOR; NATIONAL HEALTH ORGANIZATION; ORAL CONTRACEPTIVE USE; OVARIECTOMY; OVARY CARCINOMA; OVARY TUMOR; PARITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING; TUMOR CLASSIFICATION; UNITED STATES; UTERINE TUBE LIGATION;

APPENDECTOMY; EPIDEMIOLOGY; MUCINOUS OVARIAN NEOPLASMS; RISK FACTORS;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; APPENDECTOMY; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84894069772     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2013.12.011     Document Type: Article

References (31)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
2. S. Vaughan, J.I Coward, R.C. Bast Jr., A. Berchuck, J.S. Berek, and J.D. Brenton et al. Rethinking ovarian cancer: recommendations for improving outcomes Nat Rev Cancer 11 2011 719 725
3. A.M. Karst, and R. Drapkin Ovarian cancer pathogenesis: a model in evolution J Oncol 2010 2010 932371
4. J.D. Seidman, R.J. Kurman, and B.M. Ronnett Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis Am J Surg Pathol 7 2003 985 993
5. R.J. Kurman, and Ie M. Shih Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm Hum Pathol 42 2011 918 931
6. J.T. O'Connell, C.M. Hacker, and S.H. Barsky MUC2 is a molecular marker for pseudomyxoma peritonei Mod Pathol 15 2002 958 972
7. W.R. Hart Mucinous tumors of the ovary: a review Int J Gynecol Pathol 24 2005 4 25
8. L.E. Kelemen, and M. Kobel Mucinous carcinomas of the ovary and colorectum: different organ, same dilemma Lancet Oncol 12 2011 1071 1080
9. R. Thomas, D. Barnhill, F. Worsham, and W. Hoskins Krukenberg tumor of the ovary from an occult appendiceal primary: case report and literature review Obstet Gynecol 65 1985 95S 98S
10. M. Mandai, I. Konishi, Y. Tsuruta, N. Suginami, T. Kusakari, and I. Iwasaki et al. Krukenberg tumor from an occult appendiceal adenocarcinoid: a case report and review of the literature Eur J Obstet Gynecol Reprod Biol 97 2001 90 95
11. I.C. Hood, B.A. Jones, and J.C. Watts Mucinous carcinoid tumor of the appendix presenting as bilateral ovarian tumors Arch Pathol Lab Med 110 1986 336 340
12. I. Cadron, K. Leunen, T. Van Gorp, F. Amant, P. Neven, and I. Vergote Management of borderline ovarian neoplasms J Clin Oncol 25 2007 2928 2937
13. A. Ayhan, M. Gultekin, C. Taskiran, M.C. Salman, N.Y. Celik, and K. Yuce et al. Routine appendectomy in epithelial ovarian carcinoma: is it necessary? Obstet Gynecol 105 2005 719 724
14. P.G. Rose, and F.W. Abdul-Karim Isolated appendiceal metastasis in early ovarian carcinoma J Surg Oncol 64 1997 246 247
15. J. Timofeev, M.T. Galgano, M.H. Stoler, J.A. Lachance, S.C. Modesitt, and A.A. Jazaeri Appendiceal pathology at the time of oophorectomy for ovarian neoplasms Obstet Gynecol 116 2010 1348 1353
16. B.L. Harlow, D.W. Cramer, D.A. Bell, and W.R. Welch Perineal exposure to talc and ovarian cancer risk Obstet Gynecol 80 1992 19 26
17. A.F. Vitonis, L. Titus-Ernstoff, and D.W. Cramer Assessing ovarian cancer risk when considering elective oophorectomy at the time of hysterectomy Obstet Gynecol 117 2011 1042 1050
18. J.S. Lee, E.M. John, V. McGuire, A. Felberg, K.L. Ostrow, and R.A. DiCioccio et al. Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations Cancer Epidemiol Biomarkers Prev 15 2006 359 363
19. P.G. Chu, L. Chung, L.M. Weiss, and S.K. Lau Determining the site of origin of mucinous adenocarcinoma: an immunohistochemical study of 175 cases Am J Surg Pathol 35 2011 1830 1836
20. T. Guvenal, P. Dursun, P.S. Hasdemir, M. Hanhan, S. Guven, and H. Yetimalar et al. Effect of surgical staging on 539 patients with borderline ovarian tumors: A Turkish Gynecologic Oncology Group study Gynecol Oncol 131 2013 546 550
21. T. Feigenberg, A. Covens, Z. Ghorab, N. Ismiil, V. Dubé, and R.S. Saad et al. Is routine appendectomy at the time of primary surgery for mucinous ovarian neoplasms beneficial? Int J Gynecol Cancer 23 2013 1205 1209
22. J.E. Lin, S. Seo, D.M. Kushner, and S.L. Rose The role of appendectomy for mucinous ovarian neoplasms Am J Obstet Gynecol 208 2013 46.e1 46.e4
23. E. Elishaev, C.B. Gilks, D. Miller, M. Srodon, R.J. Kurman, and B.M. Ronnett Synchronous and metachronous endocervical and ovarian neoplasms: evidence supporting interpretation of the ovarian neoplasms as metastatic endocervical adenocarcinomas simulating primary ovarian surface epithelialneoplasms Am J Surg Pathol 29 2005 281 294
24. S.J. Jordan, A.C. Green, and D.C. Whiteman Webb PM; Australian Ovarian Cancer Study Group. Risk factors for benign, borderline and invasive mucinous ovarian tumors: epidemiological evidence of a neoplastic continuum? Gynecol Oncol 107 2007 223 230
25. M.A. Gates, B.A. Rosner, J.L. Hecht, and S.S. Tworoger Risk factors for epithelial ovarian cancer by histologic subtype Am J Epidemiol 171 2010 45 53
26. Collaborative Group on Epidemiological Studies of Ovarian Cancer, V. Beral, K. Gaitskell, C. Hermon, K. Moser, G. Reeves, and R. Peto Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies Lancet Oncol 13 2012 946 956
27. R.H. Young From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary: part I. Historical perspective, general principles, mucinous tumors including the Krukenberg tumor Adv Anat Pathol 13 2006 205 207
28. C.M. Feltmate, K.R. Lee, M. Johnson, J.O. Schorge, K.K. Wong, and K. Hao et al. Whole-genome allelotyping identified distinct loss-of-heterozygosity patterns in mucinous ovarian and appendiceal carcinomas Clin Cancer Res 11 2005 7651 7657
29. R.F. Chuagui, Z. Zhuang, M.R. Emmert-Buck, B.R. Bryant, F. Nogales, and F.A. Tavassoli et al. Genetic analysis of synchronous mucinous tumors of the ovary and appendix Hum Pathol 27 1996 165 171
30. M. Cuatrecasas, X. Matias-Guiu, and J. Prat Synchronous mucinous tumors of the appendix and the ovary associated with pseudomyxoma peritonei. A clinicopathologic study of six cases with comparative analysis of c-Ki-ras mutations Am J Surg Pathol 20 1996 739 746
31. C. Szych, A. Staebler, D.C. Connolly, R. Wu, K.R. Cho, and B.M. Ronnett Molecular genetic evidence supporting the clonality and appendiceal origin of pseudomyxoma peritonei in women Am J Surg Pathol 154 1999 1849 1855